LOS ANGELES, Jan. 30, 2016 /Weed Wire/ — Adam Bierman, co-founder and chief executive of Los Angeles-based cannabis firm MedMen, has been tapped by the industry’s top trade organization to help lead its efforts in shaping federal marijuana policy.
Mr. Bierman has been named co-chair of the National Cannabis Industry Association’s Policy Council, an 18-member panel of the cannabis industry’s top business leaders tasked with conducting in-depth research and producing policy recommendations to the federal government to legalize and regulate cannabis.Medical marijuana is legal in 29 states and recreational marijuana is legal in California, Nevada, Massachusetts, Maine, Colorado, Oregon, Washington and Alaska. According to Wall Street investment bank Cowen and Company, Americans consume about $6 billion worth of legal marijuana annually, and that number is expected to reach $50 billion within the decade. Despite the rapid growth of the legal cannabis industry, the federal government continues to classify marijuana as a Schedule I drug.
MedMen is a leading cannabis firm based in Los Angeles with operations across North America. The Firm operates in two areas; MedMen Management offers turnkey services to cannabis license holders, and MedMen Capital makes strategic investments in key markets across the U.S. and Canada. Visit medmen.com.
About Adam Bierman:
Adam Bierman is chief executive officer and co-founder of MedMen. Mr. Bierman is a leading voice for institutional practices and clear regulations, and is at the forefront of capital formation in the cannabis space.He has been featured on various news outlets including CNBC, Bloomberg News, Forbes, Time Magazine, MarketWatch and others.